Rythmol and Humalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rythmol (propafenone hydrochloride) and Humalog (insulin lispro recombinant). Common drug interactions include multiple injuries among females and colitis among males.

The phase IV clinical study analyzes what interactions people have when they take Rythmol and Humalog. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Rythmol?

Rythmol has active ingredients of propafenone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 3,638 Rythmol users. Check the latest studies of Rythmol.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 20, 2026

35 people who take Rythmol and Humalog together, and have interactions are studied.

Rythmol and Humalog drug interactions.

What are the common drug interactions of Rythmol and Humalog, by gender? *:

female:

  1. Multiple injuries
  2. Renal failure acute (rapid kidney dysfunction)
  3. Vomiting
  4. Renal failure (kidney dysfunction)
  5. Viral infection
  6. Weight decreased
  7. Abdominal pain
  8. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  9. Diarrhoea
  10. Dyspnoea paroxysmal nocturnal (respiratory distress that awakens patients from sleep)

male:

  1. Colitis (inflammation of colon)
  2. Cough
  3. Blood bilirubin increased
  4. Blood calcium increased
  5. Blood creatinine increased
  6. Blood potassium increased
  7. Blood pressure inadequately controlled
  8. Blood triglycerides increased
  9. Blood urea increased
  10. Blood urea nitrogen/creatinine ratio increased

What are the common drug interactions of Rythmol and Humalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Renal tubular necrosis (death of kidney tubules)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Abdominal pain
  4. Anxiety
  5. Asthenia (weakness)
  6. Blood thyroid stimulating hormone decreased
  7. Chest discomfort
  8. Chest pain
  9. Diabetic nephropathy (diabetic kidney disease)
  10. Fluid overload (too much fluid in the blood)

60+:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Pneumonia
  3. Bruxism (habitual grinding of the teeth, typically during sleep)
  4. Cardiac failure congestive
  5. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  6. Cold sweat
  7. Colitis (inflammation of colon)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Cough
  10. Decreased appetite

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 8 people, 22.86%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 11.43%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 11.43%
  4. Pain: 3 people, 8.57%
  5. Multiple Myeloma (cancer of the plasma cells): 3 people, 8.57%
  6. Constipation: 3 people, 8.57%
  7. Adverse Event: 3 people, 8.57%
  8. Malignant Melanoma (skin cancer rises from melancytes): 2 people, 5.71%
  9. High Blood Pressure: 2 people, 5.71%
  10. Depression: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Rythmol and Humalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rythmol and Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rythmol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rythmol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on propafenone hydrochloride and insulin lispro recombinant (the active ingredients of Rythmol and Humalog, respectively), and Rythmol and Humalog (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: